Review of Optometry Presents a Collaboration Between New Technologies & Treatments in Eye Care and Intrepid Eye Society - Spring 2024


May 17, 2024 – May 19, 2024


Earn up to 20 COPE LIVE credits*




This activity is intended for optometrists who provide primary care optometry services, including but not limited to medical optometric services.


[italic]After completing this activity, the participant should be better able to:[/italic] 1. Diagnose and treat dry eye, meibomian gland dysfunction and blepharitis using the latest technologies and treatments. 2. Evaluate the best ways to monitor and treat glaucoma using the latest technologies and treatments. 3. Discuss the new ways optometrists can manage retinal diseases using the latest technologies and treatments. 4. Understand how to screen and treat patients with presbyopia in a clinical setting 5. Review best practices for myopia management and treatment [underline]Continuing Education Credit [/underline] This activity, COPE Activity Number(s) [bold]128188[/bold] is accredited by COPE for continuing education for optometrists. [bold][underline]Disclosure of Conflicts of Interest[/bold][/underline] Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. [bold]Planners and Managers[/bold] REG planners and managers have nothing to disclose. [bold][underline]Disclosure of Unlabeled Use[/bold][/underline] This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. [underline][bold]Disclaimer[/bold][/underline] Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.


In support of improving patient care, Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team


[underline][bold]Request for Credit[/bold][/underline] [italic]Live, In-Person Participants:[/italic] In order to be eligible to receive LIVE COPE credit for this activity, you must remain in the session room for at least [bold][italic]50 minutes of each 60 minute presentation and at least 100 minutes of each 120 minute presentation.[/bold][/italic] Attendance will be submitted to COPE, however, [bold]please be mindful that it is your responsibility to submit to your appropriate state board.[/bold] Review Education Group does not guarantee that this course has been approved for continuing education credit by your licensing board.  [bold]PLEASE NOTE: THIS PROGRAM IS NOT APPROVED BY THE FLORIDA BOARD OF OPTOMETRY OR THE TEXAS OPTOMETRY BOARD.[/bold]